Eton Pharmaceuticals Inc. (ETON) Tops Q1 EPS by 4c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.07, $0.04 better than the analyst estimate of $0.03. Revenue for the quarter came in at $17.3 million versus the consensus estimate of $14.34 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• BofA says CTA Treasury shorts stable, euro short-cover risk rises
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises